Expiration date: 06/2025

Structure and Composition

1 ampoule with 1 ml injection solution contains 2-ethyl-6-methyl-3-hydroxypyridine hydrochloride (emoxipine) 0.01 g; 10 pieces per pack.

pharmachologic effect

Mode of action - retinoprotektivnoe.

It protects the retina from the damaging effect of high light intensity, promotes the resorption of intraocular bleeding, reduces the permeability of capillaries, reduces blood clotting, increases the resistance to cerebral hypoxia and ischemia.

Testimony

Intraocular hemorrhage, diabetic retinopathy, central chorioretinal dystrophy, thrombosis of the retina central vein of the eye and its branches, post-traumatic hemorrhage complicated by myopathy, glaucoma, acute and chronic disorders of cerebral circulation ischemic and hemorrhagic nature. Protection retina by exposure to high intensity light (laser and sunburn, laser photocoagulation).

Contraindications

Hypersensitivity, pregnancy.

Side effects

Excitation (short), drowsiness, increased blood pressure, rash, local reactions: pain, burning sensation, itching, redness, induration paraorbital tissues.

Dosing and Administration

Retrobulbarno - 0.5 ml of a 1% solution of 1 times a day for 10-15 days; parabulbarno and subkonyunktivalno - by 0.2-0.5 ml of 1 times a day for 10-30 days. To protect retinal laser photocoagulation eye when administered retrobulbarly 0.5 ml per day and for 1 hour to coagulate. Then apply 0.5 ml retrobulbarno for 2-10 days every 1 day. In neurology - / m to 5.3 ml for 10-30 days 2-3 times per day.

Precautionary measures

Do not mix with others. Injecting equipment in the same syringe.

Storage conditions

In the dark place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

The shelf life

3 years.

Do not use beyond the expiration date printed on the package.